Edward M. MD Kaye Insider Trading
Get free email notifications about insider trading for Edward M. MD Kaye.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Edward M. MD Kaye. Edward M. MD Kaye is a Director in Sarepta Therapeutics, Inc. ($SRPT) and a President & CEO in Sarepta Therapeutics, Inc. ($SRPT) and a President, CEO & CMO in Sarepta Therapeutics, Inc. ($SRPT) and a SVP & Chief Medical Officer in Sarepta Therapeutics, Inc. ($SRPT) and a SVP Interim CEO & CMO in Sarepta Therapeutics, Inc. ($SRPT) and a Director in CYTOKINETICS INC ($CYTK) and a CEO in Stoke Therapeutics, Inc. ($STOK).
Address: 3450 MONTE VILLA PARKWAY, SUITE 101 BOTHELL 98021 WA
Companies in which Edward M. MD Kaye is an Insider
CYTOKINETICS INC
Trading Symbol: CYTKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Edward M. MD Kaye: Director
Holdings: 5,920 shares
Current Value: $69,264
Latest Transaction: May 13 2021
$CYTK Market Capitalization: $461.88M
$CYTK Previous Close: $11.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sarepta Therapeutics, Inc.
Trading Symbol: SRPTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Edward M. MD Kaye: Director, President & CEO, President, CEO & CMO, SVP Interim CEO & CMO, SVP & Chief Medical Officer
Holdings: 87,932 shares
Current Value: $2,564,976
Latest Transaction: Aug 07 2017
$SRPT Market Capitalization: $1.60B
$SRPT Previous Close: $29.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Stoke Therapeutics, Inc.
Trading Symbol: STOKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Edward M. MD Kaye: CEO
Holdings: 10,000 shares
Latest Transaction: Mar 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Edward M. MD Kaye
Sentiment: All, CYTK, SRPT, STOK
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | CYTK | CYTOKINETICS INC | Kaye Edward M. MD | Director | Option Exercise | A | 24.32 | 10,000 | 243,200 | 10,000 | |
May 13 2021 | CYTK | CYTOKINETICS INC | Kaye Edward M. MD | Director | Grant | A | 0.00 | 5,000 | 0 | 5,920 | 920 to 5.9 K (+543.48 %) |
Apr 05 2021 | CYTK | CYTOKINETICS INC | Kaye Edward M. MD | Director | Grant | A | 24.44 | 409 | 9,996 | 920 | 511 to 920 (+80.04 %) |
Mar 04 2021 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Option Exercise | A | 60.00 | 200,800 | 12,048,000 | 200,800 | |
Jan 04 2021 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Option Exercise | M | 0.60 | 10,000 | 6,000 | 637,801 | |
Jan 04 2021 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Buy | M | 0.60 | 10,000 | 6,000 | 10,000 | 0 to 10 K |
Dec 18 2020 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Sell | S | 60.00 | 5,194 | 311,640 | 0 | 5.2 K to 0 (-100.00 %) |